Literature DB >> 13489632

The clinical and metabolic effects of glucagon.

C EZRIN, J M SALTER, M A OGRYZLO, C H BEST.   

Abstract

Entities:  

Keywords:  GLUCAGON/effects

Mesh:

Substances:

Year:  1958        PMID: 13489632      PMCID: PMC1829548     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  The mechanism of satiety: effect of glucagon on gastric hunger contractions in man.

Authors:  A J STUNKARD; T B VAN ITALLIE; B B REIS
Journal:  Proc Soc Exp Biol Med       Date:  1955-06

2.  The relationship of epinephrine and glucagon to liver phosphorylase. III. Reactivation of liver phosphorylase in slices and in extracts.

Authors:  T W RALL; E W SUTHERLAND; W D WOSILAIT
Journal:  J Biol Chem       Date:  1956-01       Impact factor: 5.157

3.  The enhancement of peripheral glucose utilization by glucagon.

Authors:  H ELRICK; C J HLAD; T WITTEN
Journal:  J Clin Invest       Date:  1955-12       Impact factor: 14.808

4.  The effect of glucagon on carbohydrate metabolism in normal human beings.

Authors:  P K BONDY; L R CARDILLO
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

5.  The pathologic effects of large amounts of glucagon.

Authors:  J M SALTER; I W DAVIDSON; C H BEST
Journal:  Diabetes       Date:  1957 May-Jun       Impact factor: 9.461

6.  Glucagon and the regulation of carbohydrate metabolism.

Authors:  H ELRICK
Journal:  Nature       Date:  1956-05-12       Impact factor: 49.962

7.  Modification of the Reddy-Jenkins-Thorn method for the estimation of 17-hydroxycorticoids in urine.

Authors:  W J REDDY
Journal:  Metabolism       Date:  1954-11       Impact factor: 8.694

8.  Effect of glucagon on peripheral utilization of glucose in man.

Authors:  T B VAN ITALLIE; M C MORGAN; L B DOTTI
Journal:  J Clin Endocrinol Metab       Date:  1955-01       Impact factor: 5.958

9.  Effect of hyperglycemic-glycogenolytic factor and epinephrine on liver phosphorylase.

Authors:  E W SUTHERLAND; C F CORI
Journal:  J Biol Chem       Date:  1951-02       Impact factor: 5.157

10.  Purification and crystallization of hyperglycemic glycogenolytic factor (HGF).

Authors:  A STAUB; L SINN; O K BEHRENS
Journal:  Science       Date:  1953-06-05       Impact factor: 47.728

  10 in total
  3 in total

1.  THE EFFECT OF GLUCAGON ON NET SPANCHNIC BALANCES OF GLUCOSE, AMINO ACID NITROGEN, UREA, KETONES, ANS OXYGEN IN MAN.

Authors:  R F KIBLER; W J TAYLOR; J D MYERS
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

2.  [The influence of glucagon, insulin and glucose on free 17-hydroxycorticosteroids in plasma in man].

Authors:  K F WEINGES; K SCHWARZ
Journal:  Klin Wochenschr       Date:  1960-08-15

3.  Building the process-drug-side effect network to discover the relationship between biological processes and side effects.

Authors:  Sejoon Lee; Kwang H Lee; Min Song; Doheon Lee
Journal:  BMC Bioinformatics       Date:  2011-03-29       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.